JP Morgan Chase’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-218,051
Closed -$53.6M 7317
2022
Q3
$53.6M Sell
218,051
-188,471
-46% -$50.9M 0.01% 1021
2022
Q2
$101M Buy
406,522
+25,430
+7% +$6.86M 0.01% 743
2022
Q1
$126M Sell
381,092
-100,997
-21% -$31.1M 0.02% 744
2021
Q4
$173M Sell
482,089
-72,604
-13% -$24.5M 0.02% 627
2021
Q3
$181M Sell
554,693
-45,949
-8% -$15.6M 0.02% 611
2021
Q2
$187M Buy
600,642
+30,972
+5% +$9.5M 0.02% 623
2021
Q1
$182M Buy
569,670
+14,398
+3% +$4.61M 0.03% 609
2020
Q4
$180M Sell
555,272
-14,047
-2% -$3.89M 0.03% 564
2020
Q3
$155M Buy
569,319
+33,013
+6% +$9.51M 0.03% 548
2020
Q2
$130M Buy
536,306
+248,011
+86% +$49.8M 0.03% 565
2020
Q1
$41.8M Sell
288,295
-1,961
-0.7% -$326K 0.01% 874
2019
Q4
$49.5M Buy
290,256
+12,154
+4% +$2.25M 0.01% 970
2019
Q3
$49.5M Sell
278,102
-1,837
-0.7% -$397K 0.01% 955
2019
Q2
$71.4M Sell
279,939
-46,891
-14% -$12.4M 0.02% 804
2019
Q1
$93.3M Sell
326,830
-142,084
-30% -$47.2M 0.02% 674
2018
Q4
$152M Buy
468,914
+104,139
+29% +$36.2M 0.04% 488
2018
Q3
$164M Buy
364,775
+24,531
+7% +$9.67M 0.03% 519
2018
Q2
$139M Buy
340,244
+129,043
+61% +$46.7M 0.03% 558
2018
Q1
$61.5M Buy
211,201
+148,950
+239% +$37.7M 0.01% 835
2017
Q4
$11.7M Buy
62,251
+34,425
+124% +$6.43M ﹤0.01% 2000
2017
Q3
$4.52M Buy
27,826
+13,732
+97% +$2.08M ﹤0.01% 2635
2017
Q2
$2.02M Buy
14,094
+680
+5% +$91.4K ﹤0.01% 3041
2017
Q1
$1.68M Sell
13,414
-13,115
-49% -$1.52M ﹤0.01% 3140
2016
Q4
$2.99M Sell
26,529
-5,974
-18% -$692K ﹤0.01% 2825
2016
Q3
$4.18M Buy
32,503
+5,607
+21% +$672K ﹤0.01% 2376
2016
Q2
$2.94M Buy
26,896
+1,150
+4% +$114K ﹤0.01% 2597
2016
Q1
$2.44M Sell
25,746
-2,493
-9% -$210K ﹤0.01% 2596
2015
Q4
$2.55M Sell
28,239
-4,383
-13% -$372K ﹤0.01% 2633
2015
Q3
$3.03M Buy
+32,622
New +$2.87M ﹤0.01% 2539
2014
Q1
Sell
-39,828
Closed -$1.06M 4021
2013
Q4
$1.06M Sell
39,828
-22,912
-37% -$566K ﹤0.01% 3125
2013
Q3
$1.2M Sell
62,740
-22,084
-26% -$505K ﹤0.01% 3154
2013
Q2
$1.83M Buy
+84,824
New +$1.7M ﹤0.01% 2852

Other funds holding ABMD